Literature DB >> 12680519

Cardiac adverse events following smallpox vaccination--United States, 2003.

.   

Abstract

During January 24-March 21, smallpox vaccine was administered to 25,645 civilian health-care and public health workers in 53 jurisdictions as part of an effort to prepare the United States in the event of a terrorist attack using smallpox. Seven cases of cardiac adverse events have been reported among civilian vaccinees since the beginning of the smallpox vaccination program. In addition, 10 cases of myopericarditis have been reported among military vaccinees. This report summarizes data on the seven cases reported among civilians and provides background information on recent military vaccinees. Although a causal association between vaccination and adverse cardiac events in the civilian population is unproven, as a precautionary measure, CDC recommends that persons with physician-diagnosed cardiac disease with or without symptoms (e.g., previous myocardial infarction, angina, congestive heart failure, or cardiomyopathy) be excluded from vaccination during this smallpox preparedness program.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12680519

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  15 in total

1.  Bioterrorism and compulsory vaccination.

Authors:  Tom Jefferson
Journal:  BMJ       Date:  2004-09-04

2.  Comparison of smallpox outbreak control strategies using a spatial metapopulation model.

Authors:  I M Hall; J R Egan; I Barrass; R Gani; S Leach
Journal:  Epidemiol Infect       Date:  2007-01-12       Impact factor: 2.451

3.  Preparedness for a smallpox outbreak: comparing metrics for assessing levels of vaccination among health-care workers by state.

Authors:  S B Bass; S B Ruzek; T F Gordon; A L Hanlon
Journal:  Epidemiol Infect       Date:  2006-09-06       Impact factor: 2.451

4.  Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.

Authors:  Jeffrey S Kennedy; Marc Gurwith; Cornelia L Dekker; Sharon E Frey; Kathryn M Edwards; Julie Kenner; Michael Lock; Cyril Empig; Shigeru Morikawa; Masayuki Saijo; Hiroyuki Yokote; Kevin Karem; Inger Damon; Mark Perlroth; Richard N Greenberg
Journal:  J Infect Dis       Date:  2011-09-15       Impact factor: 5.226

5.  A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects.

Authors:  Michael C Keefer; Sharon E Frey; Marnie Elizaga; Barbara Metch; Stephen C De Rosa; Paulo F Barroso; Georgia Tomaras; Massimo Cardinali; Paul Goepfert; Artur Kalichman; Valérie Philippon; M Juliana McElrath; Xia Jin; Guido Ferrari; Olivier D Defawe; Gail P Mazzara; David Montefiori; Michael Pensiero; Dennis L Panicali; Lawrence Corey
Journal:  Vaccine       Date:  2011-01-07       Impact factor: 3.641

6.  Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice.

Authors:  Liyanage P Perera; Thomas A Waldmann; Joseph D Mosca; Nicole Baldwin; Jay A Berzofsky; SangKon Oh
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

7.  Myocarditis and pericarditis are rare following live viral vaccinations in adults.

Authors:  Jennifer Kuntz; Bradley Crane; Sheila Weinmann; Allison L Naleway
Journal:  Vaccine       Date:  2018-02-15       Impact factor: 3.641

Review 8.  Bioterrorism and the nervous system.

Authors:  M H Han; J R Zunt
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 6.030

9.  Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in Africa.

Authors:  Claudia Schmidt; Walter Jaoko; Gloria Omosa-Manyonyi; Pontiano Kaleebu; Juliet Mpendo; Annet Nanvubya; Etienne Karita; Roger Bayingana; Linda-Gail Bekker; Elwyn Chomba; William Kilembe; Maphoshane Nchabeleng; Julien Nyombayire; Gwynn Stevens; Paramesh Chetty; Jennifer Lehrman; Josephine Cox; Susan Allen; Len Dally; Carol Smith; Patricia E Fast
Journal:  Hum Vaccin Immunother       Date:  2013-12-27       Impact factor: 3.452

10.  Prospective surveillance for cardiac adverse events in healthy adults receiving modified vaccinia Ankara vaccines: a systematic review.

Authors:  Marnie L Elizaga; Sandhya Vasan; Mary A Marovich; Alicia H Sato; Dale N Lawrence; Bernard R Chaitman; Sharon E Frey; Michael C Keefer
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.